Dr. Ibrahim Salman, Associate Professor of Pharmacology at the Alfaisal College of Pharmacy, has been honored as a finalist for the Science-PINS Prize for Neuromodulation. His award-winning research on electroceuticals titled “Advancing cardiovascular neuromodulation: Aortic baroreceptor afferents act as targets for blood pressure control in hypertension” is published in the prestigious journal of Science, one of the highest-impact and well-renowned journals in the World today.
The Science & PINS Prize is awarded for innovative research that modulates neural activity through physical (electrical, magnetic, optical) stimulation of targeted sites in the nervous system with implications for translational medicine. Established in 2016, the prize is administered by Science and awarded annually for outstanding research as described in a 1,000-word essay based on research performed in the past three years. Dr. Ibrahim’s winning research essay, selected for it’s potential to revolutionize the treatment of hypertension, is accessible here: Advancing cardiovascular neuromodulation: Aortic baroreceptor afferents act as targets for blood pressure control in hypertension | Science
Additionally, Dr. Ibrahim Salman was also featured prominently by Science Magazine in a Protostar profile interview, offering valuable insights into the impact of his research. The full interview can be found here: ScienceAdviser: There’s water on Mars—but we’ll probably never reach it | Science | AAAS
Dr. Salman’s research demonstrates the potential of neuromodulation technology, specifically the targeting of aortic baroreceptor afferents, to provide a more precise and energy-efficient approach to blood pressure control. By reducing the need for ultrahigh charge stimulation, this innovative method can minimize side effects and enhance patient safety, offering new possibilities for treating resistant hypertension. His work also underscores the importance of considering factors like side selection for surgical intervention and sex differences when developing more tailored and effective experimental research.
As Dr. Salman reflects, he hopes his work inspires others in the field to continue pushing the boundaries of what’s possible: “Even if there is technology in place, I don’t think that should discourage people from looking for better targets and better treatments. Is it working perfectly? Can we improve it even more?”
Alfaisal University proudly commends Dr. Ibrahim Salman, PhD for this monumental achievement and his contributions to advancing solutions for critical medical challenges. His work embodies the spirit of scientific inquiry that is central to our mission and the culture we cultivate as an institution.
